Farmas USA

Aquí lo explican:

http://www.reuters.com/article/2014/02/06/ariad-board-idUSL2N0L31A320140206

Pero no sé si será por esto...

rumores de BO. lo de siempre. especulación la compra por parte del fondo Sarissa Capital Management, y la representación que pide en la junta. etc.

http://www.thestreet.com/story/12314564/1/biotech-stock-mailbag-furiex-la-jolla-pharma-sarepta.html?puc=yahoo&cm_ven=YAHOO

FURIEX, LA JOLLA , SAREPTA

Del Bastado, para quien lo quiera leer

pues la pone bonita, a perdido un 10% la jolla y a los panadero también no?

Ok, gracias. Ya sé porque LJPC está hundida. Que simpático es este hombre.

La Jolla Pharmaceuticals (LJPC_) on Twitter and now Seeking Alpha. Could this be the turnaround story of 2014?

No. La Jolla is a hedge fund roach motel. Stay out.

I recommend reading Ross Klosterman's exhaustive and well-researched account of La Jolla. He does a good job tracing the history of the company, including the gnarly provenance of its lead compound, the galectin inhibitor GCS-100. He also delves into the complicated ownership structure of La Jolla, which includes big stakes controlled by a trio of San Diego hedge funds and the Baker Brothers.

Klosterman views the involvement of "smart" healthcare hedge funds as a positive and one reason why he decided to invest in La Jolla. I look at the situation much differently. What I see are hedge funds who gained control of a struggling, essentially insolvent, La Jolla at incredibly favorable prices, threw some lipstick on the pig and are now trying to sell the company to retail investors like it was a piece of fine art. Don't fall for it.

aquí no lees ni escuchas hablar a un analista así de una empresa ni poniendole una pistola en la cabeza. no se corta un pelo, claro solo le quedan los de la barba. :)

After Klosterman's article was published, La Jolla pushed through a 1-for-50 reverse stock split, but the company also authorized 12 billion (yes, billion) shares of common stock and 8 million preferred shares, which may be used for dilutive financings in the future. Scary.

La Jolla also just moved to the Nasdaq from the bulletin boards, so expect to see a lot more investor "marketing." Next week, La Jolla executives are in New York soliciting meetings with investors via an investor relations/research firm with close ties to the San Diego hedge funds.

La madre que lo parió debe ser una santa

Edito: $heff sale al rescate de su inversión

$LJPC..$7.30...Management did change it as they went from a bloated OTCBB to a Nasdaq stock. Patience definitely required here with catalysts in March. It trades with low volume because of the R/S. It has a first-in-class product with GCS-100. Galectin-3 has been validated with the assay of $BGMD. Biotech is risky and it requires patience on these plays which is why you scale in and don't bet the farm on it.

http://ljpc.com/wp-content/uploads/2013/10/Bio-Investor-Presentation-2013.pdf

DRRX
Jooo, esta bruja parece que quiere volar pero sin el palo de la escoba, (Poco volumen) abre a 2.07 y hace un GAP a 2.69 en segundos para luego cerrarlo.